​

enVVeno Medical Stock (NASDAQ:NVNO)

RevenueOwnershipFinancialsChart
enVVeno Medical by TradingView

Previous Close

$2.53

52W Range

$2.45 - $6.97

50D Avg

$3.23

200D Avg

$4.64

Market Cap

$43.66M

Avg Vol (3M)

$164.72K

Beta

1.22

Div Yield

-

NVNO Company Profile

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

31

IPO Date

May 31, 2018

Website

NVNO Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 19Dec 18
Royalty Income$31.24K$116.15K
Contract Research - Related Party-$70.40K

Fiscal year ends in Dec 23 | Currency in USD

NVNO Financial Summary

Dec 23Dec 22Dec 21
Revenue---
Operating Income$-25.24M$-24.93M$-16.89M
Net Income$-23.52M$-24.30M$-16.20M
EBITDA$-24.69M$-24.51M$-16.75M
Basic EPS$-1.91$-2.16$-1.87
Diluted EPS$-1.91$-2.16$-1.87

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

TickerCompany
OFIXOrthofix Medical Inc.
LUNGPulmonx Corporation
SRDXSurmodics, Inc.
LIVNLivaNova PLC
KIDSOrthoPediatrics Corp.
AIMDAinos, Inc.
LNSRLENSAR, Inc.
SSKNSTRATA Skin Sciences, Inc.
IRIXIRIDEX Corporation
AXGNAxoGen, Inc.
TNONTenon Medical, Inc.
RXSTRxSight, Inc.